GB1544908A
(en)
*
|
1975-07-08 |
1979-04-25 |
Chembiomed Ltd |
Artificial oligosaccharide antigenic determinants
|
US4362720A
(en)
*
|
1977-04-14 |
1982-12-07 |
Chembiomed Ltd. |
Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals
|
GB1603609A
(en)
*
|
1977-04-14 |
1981-11-25 |
Chembiomed Ltd |
O-protected 2-azido-2-deoxy-glycosyl nitrates
|
SE445013B
(sv)
*
|
1979-06-21 |
1986-05-26 |
Landstingens Inkopscentral |
Medel for att forebygga eller behandla infektioner hos menniskor och djur
|
SE8001748L
(sv)
*
|
1980-03-05 |
1981-09-06 |
Kaellenius Gunilla |
Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
|
EP0058665B1
(fr)
*
|
1980-05-09 |
1986-02-26 |
LEFFLER, Hakon |
Derives d'hydrate de carbone pour inhiber l'adherence bacterienne
|
US4435389A
(en)
|
1980-07-07 |
1984-03-06 |
Kabushiki Kaisha Yakult Honsha |
Composition for promoting growth of bifidobacteria
|
CA1203532A
(fr)
*
|
1980-07-10 |
1986-04-22 |
Chembiomed Ltd. |
Synthese de determinants antigeniques pours les tumeurs
|
US4767845A
(en)
*
|
1980-07-10 |
1988-08-30 |
Chembiomed, Ltd. |
Synthesis of tumor antigenic determinant
|
US4794176A
(en)
*
|
1981-06-26 |
1988-12-27 |
Chembiomed |
Synthesis of tumor antigenic determinant
|
JPS5823847B2
(ja)
*
|
1981-02-06 |
1983-05-18 |
株式会社 林原生物化学研究所 |
抗ヒト蛋白質抗体の製造方法
|
DE3106815A1
(de)
*
|
1981-02-24 |
1982-09-09 |
Behringwerke Ag, 3550 Marburg |
"chemische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antigene oder immunadsorbentien"
|
US5144011A
(en)
*
|
1981-06-26 |
1992-09-01 |
Boston University |
Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers
|
US4631190A
(en)
*
|
1981-06-26 |
1986-12-23 |
Shen Wei C |
Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers
|
FR2509313A1
(fr)
*
|
1981-07-08 |
1983-01-14 |
Choay Sa |
Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
|
US4987223A
(en)
*
|
1981-12-23 |
1991-01-22 |
Choay S.A. |
Derivatives of the uronic acid
|
DE3220427A1
(de)
*
|
1982-05-29 |
1983-12-01 |
Behringwerke Ag, 3550 Marburg |
Ss-d-galactosederivate, verfahren zu ihrer herstellung und ihre verwendung
|
EP0111005B1
(fr)
*
|
1982-06-03 |
1988-04-20 |
Otsuka Pharmaceutical Co., Ltd. |
Antigènes de fucose, leur procédé de préparation et anticorps permettant de les distinguer, un kit pour diagnostiquer le cancer contenant les antigènes de fucose et une méthode pour déterminer les chaînes sacchandiques associées au cancer
|
JPS59164798A
(ja)
*
|
1983-03-09 |
1984-09-17 |
Rikagaku Kenkyusho |
シアル酸含有糖脂質誘導体
|
US4572907A
(en)
*
|
1984-03-22 |
1986-02-25 |
Abbott Laboratories |
High caloric product for I.V. administration
|
DE3422246C1
(de)
*
|
1984-06-15 |
1986-03-27 |
Pfeifer & Langen, 5000 Köln |
Verfahren zur Herstellung monovalenter Haptene
|
DK17685D0
(da)
*
|
1985-01-14 |
1985-01-14 |
Hans Goeran Magnusson |
Glycosidderivater
|
IT1213330B
(it)
*
|
1986-08-28 |
1989-12-20 |
Rol Spa |
Tensioattivi derivati da idrossiacidi bi- o tri-carbossilici.
|
US5122112A
(en)
*
|
1986-11-21 |
1992-06-16 |
Imre Corporation |
Antigen-specific removal of circulating immune complexes
|
US5034516A
(en)
*
|
1987-08-04 |
1991-07-23 |
University Of Ottawa |
Synthetic antigens of sialic acid and derivatives thereof
|
US5192661A
(en)
*
|
1987-08-04 |
1993-03-09 |
University Of Ottawa |
Multicomponent kit containing an antibody to a synthetic antigen of sialic acid
|
US4935503A
(en)
*
|
1988-05-05 |
1990-06-19 |
Biomira, Inc. |
Azidochlorination and diazidization of glycals
|
US5075433A
(en)
*
|
1988-08-05 |
1991-12-24 |
Eastman Kodak Company |
Substituted-3-sulfatoglucuronic acid antigens
|
US5240601A
(en)
*
|
1988-11-09 |
1993-08-31 |
Chembiomed, Ltd. |
Affinity supports for hemoperfusion
|
US5149425A
(en)
*
|
1988-11-09 |
1992-09-22 |
Chembiomed, Ltd. |
Affinity supports for hemoperfusion
|
US5059443A
(en)
*
|
1989-08-30 |
1991-10-22 |
The Procter & Gamble Co. |
Esterified ethoxylated alkyl glycosides useful in low calorie fat-containing food compositions
|
US5374655A
(en)
*
|
1991-06-10 |
1994-12-20 |
Alberta Research Council |
Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
|
US5352670A
(en)
*
|
1991-06-10 |
1994-10-04 |
Alberta Research Council |
Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
|
US5646123A
(en)
*
|
1991-06-10 |
1997-07-08 |
Alberta Research Council |
Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
|
AU666128B2
(en)
*
|
1991-08-23 |
1996-02-01 |
Alberta Research Council Inc. |
Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
|
WO1993008205A1
(fr)
*
|
1991-10-15 |
1993-04-29 |
The Scripps Research Institute |
Preparation d'hydrates de carbone fucosyles par synthese a flucosylation enzymatique de nucleotides de sucres, et regeneration in situ de gdp-fucose
|
US6319695B1
(en)
|
1991-10-15 |
2001-11-20 |
The Scripps Research Insitute |
Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
|
EP0650492A1
(fr)
*
|
1992-05-26 |
1995-05-03 |
Alberta Research Council |
Reduction de l'inflammation par administration dependante dans le temps d'oligosaccharides glycosides relatifs a des determinants de groupes sanguins
|
AU667530B2
(en)
*
|
1992-05-28 |
1996-03-28 |
New York Blood Center, Inc., The |
Removal of antibodies from blood-derived compositions while retaining coagulation factors
|
US5977079A
(en)
*
|
1992-08-21 |
1999-11-02 |
Alberta Research Council Edmonton |
Compositions for attenuating antibody- mediated xenograft rejection in human recipients
|
US5376531A
(en)
*
|
1992-09-03 |
1994-12-27 |
Northwestern University |
Method of detecting cancer
|
US5484773A
(en)
*
|
1994-02-14 |
1996-01-16 |
Alberta Research Council |
Treatment of antibiotic associated diarrhea
|
WO1995029927A2
(fr)
*
|
1994-05-02 |
1995-11-09 |
Biomira, Inc. |
Procede de preparation de glycosides d'antigenes glucidiques associes aux tumeurs
|
US5785966A
(en)
*
|
1994-06-15 |
1998-07-28 |
Coles; John G. |
Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
|
US5641760A
(en)
*
|
1994-06-17 |
1997-06-24 |
Pence, Inc. |
Method of treating candida infection
|
US5811409A
(en)
*
|
1995-06-05 |
1998-09-22 |
Synsorb Biotech, Inc. |
Treatment of cholera
|
US5627163A
(en)
*
|
1995-06-05 |
1997-05-06 |
Synsorb Biotech, Inc. |
Treatment of traveller's diarrhea
|
US5637576A
(en)
*
|
1995-06-05 |
1997-06-10 |
Synsorb Biotech, Inc. |
Treatment of traveller's diarrhea
|
US5661131A
(en)
*
|
1995-06-05 |
1997-08-26 |
Synsorb Biotech, Inc. |
Treatment of cholera
|
USRE39245E1
(en)
*
|
1995-12-21 |
2006-08-22 |
Procur Ab |
Galactopyranosides and their use
|
US5891860A
(en)
*
|
1996-03-11 |
1999-04-06 |
Synsorb Biotech, Inc. |
Treatment of traveller's diarrhea
|
US6069137A
(en)
*
|
1996-03-11 |
2000-05-30 |
Synsorb Biotech, Inc. |
Treatment of traveller's diarrhea
|
JPH107575A
(ja)
*
|
1996-06-21 |
1998-01-13 |
Synsorb Biotec Inc |
細菌性赤痢の処置
|
US6063769A
(en)
*
|
1996-11-14 |
2000-05-16 |
Synsorb Biotech, Inc. |
1-thiogalactose derivatives
|
US6087339A
(en)
*
|
1996-11-14 |
2000-07-11 |
Synsorb Biotech, Inc. |
Saccharide derivatives
|
US5932554A
(en)
*
|
1996-11-14 |
1999-08-03 |
Synsorb Biotech, Inc. |
1-galactose derivatives
|
US5968907A
(en)
*
|
1996-11-14 |
1999-10-19 |
Synsorb Biotech, Inc. |
1-thiogalactose derivatives
|
US6686457B1
(en)
*
|
1996-12-23 |
2004-02-03 |
Kurt Nilsson |
Material
|
US7014049B2
(en)
*
|
1996-12-23 |
2006-03-21 |
Glycorex Transplantation Ab |
Device for bio-affinity material
|
GB2325233B
(en)
*
|
1997-05-16 |
2001-07-18 |
Norsk Hydro As |
Substrates having bound polysaccharides and bacterial nucleic acids
|
US5888750A
(en)
*
|
1997-05-30 |
1999-03-30 |
Synsorb Biotech, Inc. |
Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
|
CA2299295C
(fr)
*
|
1997-08-08 |
2010-11-30 |
Aventis Pharma Deutschland Gmbh |
Derives substitues du tetrahydropyrane, leur procede de production, leur utilisation comme medicaments ou agents diagnostiques, et medicaments les contenant
|
US5952454A
(en)
*
|
1997-12-12 |
1999-09-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Linking compounds useful for coupling carbohydrates to amine-containing carriers
|
ZA991410B
(en)
|
1998-02-23 |
1999-10-06 |
Synsorb Biotech Inc |
Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
|
US6174867B1
(en)
|
1998-05-08 |
2001-01-16 |
Synsorb Biotech, Inc. |
1-galactose derivatives having a carbon- or nitrogen-containing aglycon linkage
|
US6087342A
(en)
*
|
1998-05-15 |
2000-07-11 |
Fmc Biopolymer As |
Substrates having bound polysaccharides and bacterial nucleic acids
|
US6013635A
(en)
*
|
1998-05-28 |
2000-01-11 |
Synsorb Biotech, Inc. |
Treatment of C. difficile toxin B associated conditions
|
US6358930B1
(en)
|
1998-05-28 |
2002-03-19 |
Synsorb Biotech Inc. |
Treatment of C. difficile toxin B associated conditions
|
US6310043B1
(en)
|
1998-08-07 |
2001-10-30 |
Governors Of The University Of Alberta |
Treatment of bacterial infections
|
US5962423A
(en)
*
|
1998-08-07 |
1999-10-05 |
The Governors Of The University Of Alberta |
Treatment of bacterial dysentery
|
SE9904581D0
(sv)
*
|
1999-12-15 |
1999-12-15 |
A & Science Invest Ab |
A novel helicobacter pylori-binding substance and use thereof
|
US20040022784A1
(en)
*
|
2000-02-08 |
2004-02-05 |
Kurt Nilsson |
Oligosaccharide supports for e.g. removal of antibodies from blood
|
US6573375B2
(en)
|
2000-12-20 |
2003-06-03 |
Union Carbide Chemicals & Plastics Technology Corporation |
Liquid thickener for surfactant systems
|
AU2005295708A1
(en)
*
|
2004-10-13 |
2006-04-27 |
Relypsa, Inc. |
Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle
|
US20060078534A1
(en)
*
|
2004-10-13 |
2006-04-13 |
Dominique Charmot |
Toxin binding compositions
|
EP2556848A1
(fr)
*
|
2011-08-08 |
2013-02-13 |
Gambro Lundia AB |
Matière de séparation avec des ligands saccharides
|
EP2698636A1
(fr)
|
2012-08-13 |
2014-02-19 |
Fundació Institut d'Investigació Biomèdica de Bellvitge |
Procédés et réactifs pour la prévention et/ou le traitement d'un rejet de greffe
|
CN103665061B
(zh)
*
|
2013-12-05 |
2015-11-04 |
西北农林科技大学 |
一种区域选择性乙酰化甲基-d-吡喃糖苷的合成方法
|
FR3035794B1
(fr)
|
2015-05-06 |
2017-05-05 |
Elicityl |
Procede pour la purification du sang total ou d'un produit issu du sang
|
FR3035799B1
(fr)
|
2015-05-06 |
2017-05-05 |
Elicityl |
Support pour la purification de liquides biologiques
|
US10697982B2
(en)
|
2015-09-08 |
2020-06-30 |
Merck Patent Gmbh |
Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
|
US10697983B2
(en)
|
2015-09-08 |
2020-06-30 |
Merck Patent Gmbh |
Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
|
CN107290520B
(zh)
*
|
2017-06-14 |
2019-08-02 |
邵超鹏 |
测定孕妇IgG抗-A和抗-B血型抗体或人血型反定型的免疫层析试纸条
|
WO2024082390A1
(fr)
*
|
2022-10-18 |
2024-04-25 |
天津德祥生物技术股份有限公司 |
Utilisation d'un conjugué trisaccharide d'antigène de groupe sanguin dans la détection d'anticorps de groupe sanguin
|